Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03281954
Title Clinical Trial of Neoadjuvant Chemotherapy With Atezolizumab or Placebo in Patients With Triple-Negative Breast Cancer Followed After Surgery by Atezolizumab or Placebo
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors NSABP Foundation Inc

triple-receptor negative breast cancer



Age Groups: adult | senior
Covered Countries USA | CAN

No variant requirements are available.